Skip to main content
logo
Frontier Biotechnologies Inc. (SHA:688221)
China flag China · Delayed Price · Currency is CNY
22.07
+1.41 (6.82%)
At close: Aug 20, 2026

Frontier Biotechnologies Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
8,2676,7613,6563,7166,4656,688
Market Cap Growth
15.61%84.94%-1.61%-42.53%-3.33%-3.43%
Enterprise Value
8,0096,4433,4423,0555,3915,318
Last Close Price
22.0718.059.769.9217.2618.59

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
21.0854.8028.2432.5276.29165.12
PB Ratio
7.467.713.202.773.873.65
P/TBV Ratio
8.389.023.693.344.574.26

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
20.4252.2226.5926.7463.61131.30

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.430.460.360.280.170.16
Net Debt / Equity Ratio
-0.23-0.35-0.39-0.42-0.58-0.65
Net Debt / EBITDA Ratio
-8.721.301.871.862.734.19
Net Debt / FCF Ratio
-10.211.202.321.422.242.08
Asset Turnover
0.220.070.070.050.030.02
Inventory Turnover
1.361.581.911.421.471.91
Quick Ratio
2.492.212.812.654.643.76
Current Ratio
3.542.453.092.905.073.95
Return on Equity (ROE)
0.31%-26.56%-16.21%-21.83%-20.38%-13.36%
Return on Assets (ROA)
0.36%-9.59%-8.76%-9.45%-10.08%-7.95%
Return on Capital Employed (ROCE)
0.70%-22.30%-19.50%-19.60%-18.70%-15.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
0.04%-3.96%-5.51%-8.85%-5.52%-3.89%
FCF Yield
0.31%-3.79%-5.23%-10.67%-6.64%-8.53%
Buyback Yield / Dilution
-0.42%0.17%0.24%-2.69%-0.79%-25.23%